Author predicts healthcare and pharmaceutical stocks, currently undervalued, will see significant gains as their expected blowout earnings growth (40% for sector next quarter, 20% for full year, 61% for pharma next quarter) gets priced into the market.
"the opportunity here something I wanted to point out because it doesn't appear to be priced into the the market yet is in healthcare stocks specifically in Pharmaceuticals... stocks in the sector seen posting blowout earnings growth of 40% and 20% for the full year the second best sector for profit growth... Pharmaceutical companies are expected to see the lion Sheriff growth with earnings up 61% in the next quarter"